





















































































































1.1	Schwann	cells,	the	major	glial	cells	of	the	peripheral	nervous	system	Schwann	cells	are	the	major	glial	cell	type	found	in	the	peripheral	nervous	system	(PNS).	 The	 term	 ‘Schwann	 cell’	 encompasses	 several	 functionally	 distinct	vertebrate	 glial	 cell	 types	 of	 common	 origin.	 Mature	 Schwann	 cells	 classically	function	to	support	motor	and	sensory	neurons	by	facilitating	the	transmission	of	action	potentials	 from	sensory	receptors	 to	 the	central	nervous	system	(CNS),	or	from	 the	 CNS	 to	 muscle	 fibers.	 The	 importance	 of	 this	 supporting	 role	 is	 most	apparent	 when	 it	 is	 perturbed	 in	 neuropathies	 such	 as	 Charcot-Marie-Tooth	disease,	where	mutations	in	Schwann	cells	can	severely	impair	motor	and	sensory	function.	Although	restricted	to	vertebrates	in	the	literal	sense,	many	invertebrates	such	 as	Drosophila	 possess	 peripheral	 glia	 that	 share	many	 of	 the	 functions	 and	characteristics	 of	 Schwann	 cells.	 This	 long	 evolutionary	 history	 hints	 at	 the	essential	 functions	 these	 glial	 cells	 provide	 in	 the	 PNS,	 which	 are	 necessary	 for	complex	multicellular	life.	












































attracted	 to	 axons	by	 contact	or	 a	diffusible	 cue	 (Bhattacharyya	et	 al.	 1994)	 and	once	 they	 are	 at	 the	 nerve	 roots,	 these	 neural	 crest	 cells	 feed	 into	 chains	 of	Schwann	 cell	 precursors	 that	 co-migrate	 with	 growth	 cones	 into	 the	 periphery	(Klämbt	2010).	Schwann	cell	precursors	actively	proliferate	by	mitosis	whilst	they	are	 migrating	 along	 the	 growing	 axons	 (Speidel	 1932).	 Thus,	 Schwann	 cell	precursors	 achieve	 complete	 coverage	 of	 the	 nascent	 peripheral	 nerves	 by	 a	combination	 of	 differentiation	 from	 the	 neural	 crest	 and	 cell	 division,	 while	moving	 along	 the	 axons	 to	 settle	 in	 the	 periphery.	 The	 relative	 contributions	 of	migration	and	proliferation	to	achieve	complete	coverage	of	the	nerve	are	unclear.	If	proliferation	is	blocked,	co-migration	of	peripheral	glia	and	growth	cones	along	the	 zebrafish	 lateral	 line	 is	 unaffected	 (Lyons	 et	 al.	 2005),	 indicating	 that	proliferation	is	not	critical	in	this	animal	model.	













outgrowth,	is	also	expressed	by	Schwann	cell	precursors	(Curtis	et	al.	1992;	Jessen	et	 al.	 1994;	Dong	 et	 al.	 1999).	 To	 date,	 the	 only	 Schwann	 cell	 precursor-specific	marker	 is	 the	 cell	 adhesion	 molecule	 (CAM)	 N-cadherin.	 The	 absence	 of	endoneurial	 space	 between	 the	 Schwann	 cell	 precursors	 is	 correlated	 with	 N-cadherin	 expression	 and	 the	 presence	 of	 extensive	 cell-cell	 contacts.	 N-cadherin	expression	is	especially	high	in	the	Schwann	cell	precursors	at	the	growing	nerve	front,	in	close	proximity	to	the	axonal	growth	cones	(Wanner,	Guerra,	et	al.	2006a).	
1.3.2	Immature	Schwann	cell	
















An illustration of the molecular pathways involved in radial sorting of axons, 
adapted from Feltri et al, 2015. Depicted are two immature Schwann cells, 
inserting processes into an axon bundle. Cyclic AMP (cAMP), Dystroglycan 
(DG), Focal adhesion kinase (FAK), Grb2-Associated Binder (Gab), Gpr (G 
protein-coupled receptor), Histone deacetylase (Hdac), Integrin (α6β1, α7β1), 
Integrin-linked kinase (ILK), Jun activation domain–binding (Jab), lymphoid cell 
kinase (Lck), Leucine-rich-glioma inactivated (Lgi), Liver Kinase B (Lkb), 
Neurofibromin (Nf), Neural Wiskott–Aldrich syndrome protein (N-Wasp) and 




1.3.2	Myelinating	Schwann	cell	An	 immature	 Schwann	 cell	 that	 has	 become	 associated	 with	 a	 solitary	 large-diameter	axon	is	termed	a	pro-myelinating	Schwann	cell.	This	is	a	transient	stage,	occurring	 before	 the	 onset	 of	 axonal	 ensheathment	 in	 the	 days	 following	 birth.	Myelination	 begins	 when	 the	 leading	 edge	 of	 the	 Schwann	 cell	 inner-mesaxon	starts	 to	 extend	 and	 wrap	 spirally	 around	 the	 axon.	 This	 extensive	 membrane	synthesis	and	spiral	wrapping	of	the	axon	generates	the	multi-lamella	structure	of	myelin	(Bunge	et	al.	1989).	Parallels	between	the	two	morphological	processes	of	myelination	 and	 cell	 migration	 can	 be	 seen,	 such	 as	 the	 requirement	 for	 actin	polymerisation	 for	membrane	extension	and	 the	 involvement	of	 the	RhoGTPases	and	other	modulators	of	the	actin	cytoskeleton.	




during	radial	sorting,	as	described	earlier.	To	correctly	implicate	the	involvement	of	 specific	 cytoskeletal	 regulators	 in	 controlling	myelination,	 radial	 sorting	must	first	proceed	normally	and	this	makes	in	vivo	evidence	hard	to	obtain.		 	The	 actin-regulating	 RhoGTPases	 Cdc42	 and	 Rac1	 are	 both	 required	 for	correct	 radial	 sorting	 (Benninger	 et	 al.	 2007;	Nodari	 et	 al.	 2007),	 however	 some	Schwann	 cells	 in	 these	 conditional	 knockout	 mice	 do	 progress	 to	 the	 pro-myelinating	 stage.	 These	 cells	 are	 arrested	 and	 do	 not	 go	 on	 to	 myelinate,	indicating	an	 involvement	 in	both	ensheathment	and	radial	sorting	 for	these	two	proteins	(Feltri	et	al.	2008;	Guo	et	al.	2012).		




Schwann	 cells	 has	 been	 referred	 to	 as	 ‘transdifferentiation’	 rather	 than	‘dedifferentiation’.	Another	important	difference	is	that	Bungner	Schwann	cells	are	for	 the	most	part	without	 any	axonal	 contact.	All	 other	 cells	 of	 the	 Schwann	 cell	lineage	 are	 in	 constant	 association	 with	 axons.	 The	 Bungner	 Schwann	 cell	 will	quickly	re-differentiate	into	a	myelinating	or	non-myelinating	Schwann	cell	when	contact	is	re-established.		









developing	extensive	 sprouts	and	migrating	away	 from	motor	endplates,	 as	 seen	following	nerve	injury	(Hayworth	et	al.	2006).	


















and	 cell	motility.	An	 array	of	 accessory	proteins	 regulate	 the	 spatial	 distribution	and	 behaviour	 of	 the	 cytoskeleton	 subunits	 or	 polymers,	 allowing	 the	 cell	 to	integrate	extracellular	or	 intracellular	signals	 to	 trigger	dynamic	 transformations	of	 the	 cytoskeleton	 for	 events	 such	 as	 phagocytosis,	 organelle	 transport	 and	 cell	movement.	In	the	following	sections,	I	will	describe	the	molecular	biology	of	these	cytoskeletal	proteins,	with	an	emphasis	on	their	role	in	cell	migration.	
1.4.1	The	actin	cytoskeleton	Proteins	 belonging	 to	 the	 actin	 family	 are	 capable	 forming	 filaments	 (F-actin),	which	can	assemble	and	disassemble	as	required	by	the	cell.	There	are	six	highly	conserved	actin	isoforms,	however	only	two	(β-actin	and	γ-actin)	are	expressed	in	the	majority	of	cells.	Actin	monomers	are	also	referred	to	as	G-actin	due	 to	 their	globular	form,	and	to	distinguish	them	from	their	polymerised	form,	F-actin.	Actin	has	 a	 molecular	 weight	 ~42	 kDa.	 Actin	 polymerisation	 at	 the	 leading	 edge	 of	 a	migrating	cell	provides	the	force	that	allows	the	cell	membrane	to	extend	forward.	This	protrusion	at	the	front	of	the	cell	is	called	the	lamellipodium	and	its	extension	is	driven	by	 the	assembly	of	actin	monomers	 into	 filamentous	actin,	 in	a	process	known	as	treadmilling	(Pollard	&	Borisy,	2003).	




hydrolyse	ATP,	which	acts	 as	 a	 timer	 for	 the	 stability	of	F-actin	 (Bugyi	&	Carlier	2010).	




the	 growing	 barbed	 end,	 ready	 to	 insert	 additional	 actin	 subunits	 (Pring	 et	 al.	2003).	Unlike	Arp2/3,	formins	do	not	require	an	existing	actin	filament	to	induce	actin	polymerisation.	The	third	class	of	actin	nucleation	factors	 includes	Spire,	 first	 identified	 in	Drosophila.	 Spire	 has	 four	 WASP	 homology	 2	 (WH2)	 domains,	 each	 of	 which	recruit	an	actin	monomer	and	align	them	to	form	the	F-actin	nucleus	(Quinlan	et	al.	2005).			
			




1.4.1.2	Actin	elongation,	treadmilling	and	disassembly	Once	actin	 filament	polymerisation	 is	 initiated,	 F-actin	 continues	 to	 extend	at	 its	barbed	 end	 until	 it	 is	 either	 abrogated	 by	 a	 capping	 protein,	 or	 the	 pool	 of	 free	ATP-actin	is	exhausted.	The	cell	expresses	a	class	of	proteins,	referred	to	as	actin	elongation	proteins,	which	shield	the	barbed	end	from	these	capping	proteins	and	allowing	the	barbed	end	to	continue	extending.	Formins	constitute	one	member	of	this	class,	since	they	remain	attached	to	the	barbed	end	of	the	F-actin	via	their	FH2	domains.	Another	member	 is	Ena/VASP,	which	seems	 to	have	a	 less	potent	anti-capping	ability	than	formin.	There	are	conflicting	reports	on	the	protection	it	offers	to	the	barbed	end,	although	it	seems	to	depend	on	Ena/VASP	concentration	(Bear	&	Gertler	2009).	 It	 is	clear,	however,	 that	both	 formins	and	Ena/VASP	accelerate	the	 rate	 of	 F-actin	 elongation,	 up	 to	 5-fold	 and	 7-fold	 respectively	 (Chesarone	&	Goode	2009).	




filament,	 with	 the	 barbed	 end	 containing	 ATP-bound	 actin	 monomers	 and	 the	pointed	end	composed	of	mostly	ADP-bound	actin	(Bugyi	&	Carlier	2010).	In	order	for	actin	treadmilling	to	proceed,	a	constant	supply	of	ATP-actin	is	required.	 As	mentioned	 previously,	 the	 G-actin	 binding	 protein	 profilin	 captures	ADP-actin	monomers,	 catalyses	 the	 transfer	of	ADP	 to	ATP	and	delivers	 them	 to	the	barbed	end	of	the	growing	actin	filament.	This	process	requires	the	supply	of	ADP	actin,	which	is	removed	from	the	pointed	end	of	F-actin	by	ADF/Cofilin,	which	speeds	 up	 F-actin	 disassembly	 and	 therefore	 the	 liberation	 of	 ADP-actin.	 Cofilin	does	this	by	increasing	actin	disassembly	at	the	pointed	end,	and	also	by	severing	F-actin	 and	 exposing	more	pointed	 ends	 from	which	ADP-actin	 can	disassemble.	Gelsolin	 is	 another	F-actin	 severing	protein	 that	 promotes	disassembly	 (Bugyi	&	Carlier	2010).	
1.4.1.3	Capping	protein	F-actin	 Capping	 Protein	 (CP)	 is	 a	 heterodimeric	 protein	 that	 binds	 tightly	 to	 the	barbed	 end	 of	 F-actin,	 preventing	 the	 addition	 or	 subtraction	 of	 any	 actin	monomers.	CP	is	associated	with	lamellipodia	protrusion	and	cell	migration,	since	it	 prevents	 excessive	 elongation	 of	 F-actin	 and	 promotes	 Arp2/3	 induced	 actin	nucleation	and	branching.	Lack	of	CP	leads	to	the	formation	of	filopodia	(Takeda	et	al.	2010).	





































































1.6	c-Jun	regulation	of	cell	morphogenesis	The	transcription	factor	c-Jun	is	known	to	control	cell	shape	and	motility	through	a	number	 of	 different	mechanisms,	 it	 is	 required	 for	 tissue	morphogenesis	 during	both	mouse	 and	Drosophila	 development	 and	 also	 promotes	 the	 invasiveness	 of	cancer	cells.	
1.6.1	Dorsal	closure	Dorsal	closure	of	the	Drosophila	embryo	occurs	during	mid-embryogenesis	and	involves	the	concerted	movement	and	elongation	of	the	cells	of	the	ventral	and	lateral	epidermis,	in	the	absence	of	cell	division,	so	the	two	epithelia	meet	and	fuse	at	the	dorsal	midline.	Drosophila	mutants	that	show	a	failure	in	epidermal	closing	at	 the	 dorsal	 midline	 are	 said	 to	 possess	 the	 “dorsal	 open”	 (DO)	 phenotype.	Molecular	analysis	of	these	mutants	reveals	two	main	classes	of	genes	involved	in	dorsal	closure;	those	encoding	structural	proteins	such	as	myosin	and	components	of	 focal	adhesions,	and	those	encoding	proteins	 likely	 to	regulate	and	trigger	cell	morphogenesis	(Hou	et	al.	1997).	Basket	and	hemipterous	are	Drosophila	mutants	that	 represent	 such	 regulatory	 proteins,	 and	 encode	Drosophila	 JNK	 (DJNK)	 and	
DJNK	kinase	(DJNKK).	The	Drac	mutant,	which	is	the	homologue	of	the	mammalian	small	GTPase	Rac1	also	displays	a	DO	phenotype	(Riesgo-Escovar	&	Hafen	1997b).	In	cells	of	the	leading	edge	of	the	ventral	and	lateral	epidermis,	an	unknown	signal	activates	 the	 Rac1-JNK	 pathway	 and	 in	 turn,	 the	 downstream	 targets	 DJun	 and	




nucleus	 (Fig.	 1.7),	 and	 subsequent	 gene	 expression	 that	 initiates	 the	 cell	morphological	changes	necessary	to	drive	leading	cell	elongation,	and	thus	closure	of	 the	 dorsal	 midline	 of	 the	 embryo	 (Hou	 et	 al.	 1997;	 Riesgo-Escovar	 &	 Hafen	1997a;	Riesgo-Escovar	&	Hafen	1997b)..																




1.6.2	Mouse	eyelid	closure	Eyelid	 closure	 in	 the	 mouse	 takes	 place	 between	 E15-E16	 and	 is	 analogous	 to	dorsal	closure	in	Drosophila	as	both	processes	involve	the	extension	and	fusion	of	two	 epithelia,	 which	 requires	 cell	 morphogenesis.	 Failure	 of	 eyelid	 closure	 is	referred	 to	 as	 the	 eye-open-at-birth	 (EOB)	 phenotype.	 The	molecular	 control	 of	this	morphogenetic	event	is	also	comparable	to	that	of	dorsal	closure	as	c-Jun	lies	downstream	of	JNK	signalling,	and	induces	the	expression	of	genes	that	affect	cell	shape	and	migration.	Activin	B	 initiates	MEKK1-MKK4	signalling,	which	activates	the	JNK1/2	pathway	and	culminates	in	the	phosphorylation	of	c-Jun	(Takatori	et	al.	2008).	Conditional	deletion	of	c-Jun	and	other	proteins	in	this	pathway	causes	the	EOB	phenotype.	Keratinocytes	are	the	cells	that	compose	the	eyelid	epidermis,	and	deletion	 of	 c-Jun	 in	 these	 cells	 reduces	 their	 expression	 of	 another	 EOB	protein,	EGF	receptor	(Zenz	et	al.	2003).		








ErbB2,	 a	member	 of	 the	 epidermal	 growth	 factor	 receptor	 family	 plays	 a	significant	 role	 in	 both	 Schwann	 cell	 development	 and	 migration,	 and	 in	 the	induction	of	mammary	tumour	cell	invasion.	Both	c-Jun	and	ErbB2	are	over-																													









The mammalian PNS has the capacity to regenerate following nerve injury, an ability 
that provides a contrast with the limited regenerative capability of the CNS. This 
difference was first observed by Ramon y Cajal, who showed that peripheral nerves 
could not regenerate through central nerve graft tissue (R. Y. Cajal 1928). It was later 
shown that nerve fibers from the CNS, which are not capable of regenerating in their 
native environment, are able to grow through transplanted peripheral nerve (David & 
Aguayo 1981; Richardson et al. 1980). The results of these studies indicate that both 
PNS and CNS neurons possess the ability to regenerate, but only the PNS provides the 
necessary conditions to enable axonal regrowth. DRG sensory neurons exist in a unique 
configuration, containing a single, branched axon (referred to as pseudobipolar) that 
extends into and connects both sensory receptors in the periphery and neurons in the 
brain (via the spinal column). The two axon branches exhibit different responses to 
injury. Injury to the peripheral branch results in spontaneous regeneration with some 
recovery of sensory function, whereas injury to the central branch does not lead to 
regeneration. Significantly, if the peripheral branch lesion is followed by similar injury 
to the central branch, the central nerve does show signs of regeneration into the 
normally inhibitory environment of the spinal cord. Richardson & Issa performed an in 
vivo experiment, in which the dorsal column of the rat spinal cord was incised 
bilaterally and a sciatic nerve graft (from the right leg) was transplanted into the midline 
of the spinal cord. DRG neurons growing into the nerve graft were labeled and counted, 
and the results demonstrated that DRGs ipsilateral to the sciatic nerve transection were 
labeled positive, demonstrating that spinal axons from the DRG neurons had 
regenerated, however, no axonal regeneration into the CNS was observed from DRGs 




Pre-degeneration of the peripheral nerve graft promotes an even greater regenerative 
response from injured central axons, however, this effect is only seen in response to 
sciatic nerve crush (Oudega et al, 1994). Chong et al. demonstrated increased 
expression of GAP-43 mRNA in L4 DRG sensory neurons in the weeks following 
sciatic nerve crush, highest at 3 weeks following the conditioning injury, and persisting 
for at least 19 weeks (Chong et al, 1996). GAP-43 is a major protein kinase C (PKC) 
substrate and plays a role in neurite formation and regeneration (Benowitz et al, 1997) 
and therefore its expression is a measure of the intrinsic growth capacity of sensory 
neurons. Chong et al also reported an increase in the number of myelinated axons that 
had grown into the nerve graft from the axons of the dorsal root compared to grafts 
without crush injury, at all following time points. (Chong et al, 1996). 
Neumann and Woolf conducted an experiment in which a peripheral lesion (sciatic 
nerve transection) was made at the same time as the central lesion, and observed 
sprouting of neurites proximal to the transected dorsal column, as well as neurites 
growing into and through the lesion. This contrasted with an absence of regenerating 
nerve fibers when no peripheral lesion was made. Peripheral lesions were also made 1 
week and 2 weeks prior to the central lesion, and these led to greater neurite outgrowth, 
including beyond the lesion site (Neumann & Woolf, 1999).  Chong et al performed a 
similar experiment, in which the left dorsal roots  L4, L5 and L6 were transected, with 
or without a simultaneous crush injury to the ipsilateral sciatic nerve. The results of this 
study demonstrated little regeneration of neurites into the spinal cord in animals that did 
not have the conditioning sciatic nerve crush injury. In rats that did experience the 
conditioning lesion, most regenerating axons were found stalled at or near the dorsal 
root entry zone, however, in all cases a subpopulation of axons were observed to enter 





The existence of this ‘conditioning lesion’ effect implies that whilst the local 
environments of injured central and peripheral DRG axons have a large affect on their 
regenerative potential, there exists an intrinsic capacity for growth in these neurons, and 
this is sufficient to overcome the less favourable regenerative environment of the CNS.  
1.7.1	Initial	events	of	nerve	regeneration	
Immediately following nerve injury, the cells of the peripheral nerve respond to this 
trauma by activating their regeneration programme. The precise trigger for this is 
unknown, although it is likely to be a combination of cellular mechanical stress such as 
disruption to cell membranes, and the loss of signals such as action potentials that are 
normally present in the uninjured nerve.  
1.7.1.1	The	axonal	response	to	nerve	injury	in	distal	stump	
The axonal response to nerve injury occurs rapidly following crush or transection. The 
transected axons in the proximal stump quickly seal their ends to prevent further escape 
of axoplasm. The axons in the distal stump start to disintegrate within hours of injury, 
as part of the process of Wallerian degeneration. This process culminates in the removal 
or myelin and axonal debris from the distal stump (Chen et al. 2007; Waller 1850). The 
axons do not breakdown straight away, there is a lag of 24-48 hours in rodents 
(Lubinska 1977) and several days in humans (Chaudhry & Cornblath 1992) and remain 
electrically excitable during this time. There is evidence that degeneration in crush 
injuries is delayed by 2-3 hours compared to complete transection, and this occurs in a 
retrograde direction, compared to the anterograde degeneration seen in nerve transection 
injuries (Beirowski et al. 2005). Axonal beading and swelling, accompanied with the 
disintegration of the axonal cytoskeleton is seen at the start of axonal degeneration, and 




suggests this is an active, rather than passive process of axonal breakdown (Gaudet et 
al. 2011). This point is further supported by the Wallerian degeneration slow, or WldS 
mouse, which has much slower axonal degeneration (Lunn et al. 1989; Perry et al. 
1991). Axons in the distal stumps of WldS mice degenerate with a delay of 2-3 weeks. 
The exact nature of the WldS mutation, identified by positional cloning, consists of an 
85 Kb tandem triplication on chromosome 4 (Lyon et al. 1993; Coleman et al., 1998). 
As a result, a chimeric protein is overexpressed in neurons that consists of the first 70 
amino acids of multi-ubiquitination factor, Ufd2 fused to the coding sequence of 
D4Cole1e/Nmnat1 (nicotinamide mononucleotide adenyltransferase1) (Conforti et al., 
2000; Mack et al., 2001). Nmnat1 enzymatic activity is known to be necessary for WldS 
mediated axonal protection (Araki et al. 2004). 
1.7.1.2	The	axonal	response	to	nerve	injury	in	the	proximal	stump	
As mentioned above, the severed ends of the axons in the proximal stump of the 
transected nerve are quickly sealed to prevent excessive egress of axoplasm. Similar to 
the distal stump, there is some axonal degeneration but this is restricted to the first node 
of Ranvier proximal to the site of transection (Zochodne, 2003). Within several hours 
the axonal cytoskeleton is rearranged, with microtubules in the most distal end of the 
axon reorganized to form traps for anterogradely transported vesicles that help to form 
the growth cone organising complex (Erez et al. 2007).  
Another early event in the axonal response to injury is the activation of signals that are 
transported retrogradely to the neuronal cell body. One of the first signals is the influx 
of Calcium ions into the axon, as mentioned previously in the context of calcium-
dependent axonal degeneration. This wave of calcium can travel up to 1mm per minute 
and occurs immediately proceeding nerve injury (Mandolesi et al. 2004).  The transient 




neurons in vivo (Howard et al. 1999). Recent data has shown that retrograde Calcium 
signaling can induce the export of histone deacetylase 5 (HDAC5) via protein kinase 
Cµ from the neuronal nucleus, which accumulates at the site of axonal injury, and is 
able to deacetylate tubulin and promote axonal regeneration  (Cho et al. 2013).  
Another retrograde signaling phase occurs later and these are trafficked from the 
injury site to the soma via dynein motors.  JNK3 and JIP3 are involved in the formation 
of retrograde signaling complexes and knockout of the JNK homologue DNK in 
Drosophila shows that it is required for the upregulation of p-Jun and p-STAT3 in 
sensory neuron soma (Shin et al. 2012).  
 Dynein motors are also used to convey a separate retrograde signaling complex 
that consists of importin-α and importin β1 bound to cargo that recognise their nuclear 
localization signal binding sites.  This cargo includes p-ERK-vimentin and p-STAT3 
(Rishal & Fainzilber 2014).  
 Whilst the exact molecular pathways that switch on the motor and sensory 
neurons of the peripheral nerve to respond to injury by acquiring a regeneration-
permissive phenotype are not fully understood, changes to the cellular architecture of 
both the proximal and distal stumps, and to the injury site are well characterized, 
particularly by electron microscopy studies in the 1960s. This early work has since been 
refined using transgenic mice expressing fluorescent markers in axons and Schwann 
cells. 
 Within 1-2 days of nerve transection, the axons of the proximal stump develop 
swellings called axon endbulbs (also referred to as boutons), which may influence nerve 
regeneration by releasing molecules such as CGRP and nitric oxide (Zochodne 2008). 
At the same time as endbulbs are forming at the axon terminals, axonal sprouts appear 
as membrane outgrowths from the parent axon. Myelinated axons normally develop 




Extensive sprouting takes place, with each axon developing multiple daughter sprouts. 
Nerve crush injuries also produce axonal sprouts, and these can grow relatively easily 
into the distal stump, as the endoneurial tubes are intact and the Schwann cells that line 
these structures form the Bands of Büngner, which are permissive substrates for axons 
to regenerate on. In contrast, sprouts from the proximal stump of the transected nerve 
must advance across newly formed tissue, referred to as the ‘nerve bridge’, composed 
primarily of fibroblasts from the epineurium, and Schwann cells from the nerve stumps. 
This structure is not very favourable for axonal regrowth, and very few of the sprouts 
successfully cross the bridge (Zochodne 2008). 
1.7.1.3	Initial	changes	to	Schwann	cells	during	nerve	regeneration	
In the distal stump and at the very end of the proximal stump of the injured nerve, 
Schwann cells undergo the process of demyelination. Myelin fragmentation begins at 
the Schmidt-Lanterman Incisures (SLIs) just minutes after injury (Williams & S. M. 
Hall 1971) and by 1-2 days the myelin sheath has started to break up into ovoid 
structures. Myelin ovoids form more slowly in thicker fibers (Lubinska 1977).  It is not 
clear how myelin is broken down in the nerve, but it is known that both Schwann cells 
and macrophages make a contribution. Elimination of infiltrating macrophages by 
whole body irradiation prior to nerve injury shows that myelin breakdown occurs 
normally for the first 5 days and then slows down. This shows that the initial breakdown 
of myelin is probably carried out by Schwann cells and resident macrophages (Perry et 
al. 1995). This is supported by Arthur-Farraj et al. who show that deleting Schwann cell 
c-Jun, and thus preventing these cells from becoming activated repair cells also slows 
the rate of myelin breakdown (Arthur-Farraj et al. 2012). Recent data suggests these 
Schwann cells are not able to process myelin through the autophagy pathway, in 




A further response of Schwann cells to nerve injury is their re-entry into the cell 
cycle. Schwann cell proliferation is negligible in the adult nerve, but is strongly 
increased following injury (Abercrombie, 1946). The significance of the increased 
cellular proliferation is unclear, since inhibiting Schwann call proliferation by 
disrupting the cyclin D1 gene does not lead to a deficiency in regeneration of 
remyelination (Yang et al. 2008). The authors of this study only considered nerve crush 
injury, so it is unknown whether Schwann cell proliferation is necessary for the 
successful bridging of the inter-stump gap created by nerve transection injury. 
Following demyelination, Schwann cells in the distal stump are found aligned 
within their basal lamina tubes, where they proliferate and secrete neurotrophic factors. 
The attraction of regenerating axons to the distal nerve stump has been well documented 
(Politis et al. 1982). 
1.7.2	Schwann	cell	migration	during	nerve	injury	and	regeneration	
 I have discussed the migratory behaviour of Schwann cells in detail in the first 
section of this introduction, but only briefly touched on their migration during 
peripheral nerve regeneration. Abercrombie conducted a series of experiments that 
revealed the motile behaviour of Schwann cells in the degenerating nerve. He observed 
Schwann cells in pre-degenerated nerves ‘outwander’ from a nerve explant at rate 
proportional to the length of time they were degenerated in vivo, peaking at 19 days. In 
this study, Schwann cells only emigrated from the cross-section of the nerve explant 
(i.e. not through the epineurium) and there was a latency period of 4-5 days before 
emigration occurred, Abercrombie suggested this is the time taken for Schwann cells to 
fully demyelinate and become mobile. Very little emigration was observed from nerves 
that had not been predegenerated (Abercrombie, 1942). In later studies, Abercrombie 




measured Schwann cell outwandering, finding that reinnervation largely diminished 
emigration from the nerve of Schwann cells, but not fibroblasts, showing that Schwann 
cells lose their ability to migrate once they become re-associated with regenerating 
axons (Abercrombie et al, 1949).  
 In vivo evidence of Schwann cell migration during regeneration was first 
reported by Nageotte, who described the outgrowth from a transected nerve as a 
‘peripheral glioma’ (Frixione, 2000) and this was also described by Masson (Masson 
1932). Holmes and Young described the in vivo migratory properties of Schwann cells 
in the distal stump of the transected nerve. They observed Schwann cells migrating 
within the intact endoneurial tubes and forming an outgrowth at the end of the distal 
nerve stump. Both proximal and distal stumps formed outgrowths, however the distal 
outgrowth was much larger and more rapid. The outgrowth is progressive for several 
weeks after transection but does not continue indefinitely. Schwann cell mitoses were 
observed in cells leaving the stump so it is possible that proliferation in addition to 
migration contribute to the size of the Schwann cell outgrowth. The authors also noted 
the outgrowth of fibroblasts from the epineurium and perineurium was significant, and 
sometimes greater than the outgrowth of Schwann cells (Holmes & Young 1942; 
Holmes et al. 1940). Rexed found the Schwann cell outgrowth proceeded at a rate of up 
to 0.3mm/day, starting from the third day following transection. In the first day, the 
inter-stump gap filled with an exudate containing macrophages, fibroblasts and 
capillaries, followed by Schwann cell outgrowth at 3 days. Transection of an already 
degenerated distal stump formed two nerve stumps from which the outgrowths were 
equally intense (Rexed 1942). The asymmetry of outgrowth from the proximal and 
distal stumps following a single transection correlates with the extent of Wallerian 




cell denervation is limited to 1-2 mm from the cut site in rat, limiting the pool of cells 
that can proliferate and emigrate into the gap. 
Thomas later confirmed the findings of Young and Rexed using electron 
microscopy of sections of the ‘nerve bridge’. He found that Schwann cells emigrated 
from the distal stump in columns, continuous with the Bands of Büngner. Cells of 
perineural origin, resembling fibroblasts, come to surround these Schwann cell 
columns. This leads to the formation of multiple small fascicles in the nerve bridge, 
each surrounded by a perineurium (Thomas 1966). This had been noted previously by 
Cajal and later by Morris, who applied the term ‘compartmentation’ to the formation of 
mini-fascicles in the nerve bridge and the proximal/distal stumps. Morris found that 
compartmentation only takes place in the presence of regrowing axons (J. H. Morris et 
al. 1972). 
1.7.3	The	role	of	c-Jun	in	peripheral	nerve	regeneration	
c-Jun is a key regulator of the Schwann cell response to nerve injury. c-Jun is 
upregulated rapidly, within an hour following nerve injury (Shy et al. 1996) and its 
deletion in mouse Schwann cells prevents recovery of motor and sensory function 
(Arthur-Farraj et al. 2012). c-Jun is expressed in immature Schwann cells before birth 
(Stewart et al. 1995; Parkinson et al., 2008), however, its expression is downregulated 
when Schwann cells begin myelination. Thus, c-Jun is only expressed in non-
myelinating Schwann cells in the adult, at low levels (Shy et al, 1996; Parkinson et al, 
2008). Furthermore, c-Jun is also upregulated in peripheral neurons following nerve 
injury and is required in these cells for in vivo regeneration (Behrens et al, 2002; 
Raivich et al, 2004). c-Jun regulates the transdifferentiation of mature myelinating and 
non-myelinating Schwann cells to repair cells, or ‘Bungner Schwann cells’ that promote 




transection, there are 172 differentially regulated genes in the c-Jun cKO mouse 
compared to the control. These include genes such as GDNF, BDNF, Shh, Artemin and 
GAP-43, which fail to upregulate following injury and have been implicated in nerve 
regeneration and the trophic support of neurons. Furthermore, c-Jun protects sensory 
neurons from cell death following nerve injury, since its deletion leads to increased 
death of both large and small DRG neurons (Arthur-Farraj et al. 2012). The WldS 
mouse has limited nerve regenerative capability, in addition to the slow degradation of 
axons, as the Schwann cells remain in a differentiated state. Increased expression of c-
Jun from the low level found in WldS nerves after injury significantly enhances nerve 
regeneration  (Arthur-Farraj et al. 2012). These findings show that c-Jun controls many 
of the functions that Schwann cells carry out in their role as a repair cell in the 
regenerating nerve.  
In agreement with the above work, Fontana et al show that conditional deletion 
of c-Jun in Schwann cells perturbs motor function of the mouse whisker following 
injury to the facial nerve and dramatically increases neuronal cell death. The 
neurotrophic factors GDNF and Artemin had reduced expression in the c-Jun knockout, 
and the authors identified these proteins, along with their receptor Ret as being 
important signals that mediate the regeneration-promoting ability of c-Jun in Schwann 








The aim of this thesis was to characterise the effect of deleting c-Jun from Schwann 
cells to understand how this has such a large affect on their ability to promote 
regeneration of the peripheral nerve. I did this by analyzing the changes to Schwann cell 
morphology and migratory behaviour in the absence of c-Jun. I also wanted to uncover 
the molecular mechanism by which c-Jun controls Schwann cell morphology and cell 
migration. Finally, I wanted to see if the in vitro observations were also replicated in the 







2.1.1	Reagents	for	tissue	culture	Cytosine	arabinoside	(AraC),	dimethyl	sulphoxide	(DMSO),	bovine	serum	albumin	(BSA),	 transferrin,	 selenium,	 putrescine,	 triiodothyronine	 (T3),	 thyroxine	 (T4)	progesterone,	 dexamethasone,	 insulin,	 poly-D-lysine	 (PDL),	 poly-L-lysine	 (PLL),	laminin	 and	 2’-0-dibutyryladenosine	 3’,5’-cyclicAMP	 (dbcAMP)	 were	 obtained	from	 Sigma	 (Poole,	 UK).	 Collagenase	 was	 obtained	 from	 Worthington	 (Lorne	Laboratories,	Reading,	UK).	Dulbecco’s	modified	Eagles	medium	(DMEM),	Ham’s	F-12	medium	 and	 L-15	medium,	 horse	 serum	 and	 glutamine	 were	 obtained	 from	Invitrogen	 Ltd	 (Paisley,	 UK).	 Trypsin,	 trypsin	 EDTA	 and	 penicillin/streptomycin	were	obtained	from	PAA	(UK).	Fetal	bovine	serum	(FBS)	was	obtained	from	Perbio	(UK).	 Forskolin	was	 obtained	 from	Calbiochem	 (CA,	USA).	NRGβ-1	was	 obtained	from	R&D	Systems	 (Minneapolis,	MN,	USA).	Tissue	culture	dishes,	24	well	plates	and	 centrifuge	 tubes	 were	 obtained	 from	 VWR.	 Round	 13-mm	 coverslips	 were	obtained	from	BDH	(Lutterworth,	UK).	Transwell	6.5-mm	inserts	with	8	μm	pores	were	obtained	from	Corning	(New	York,	USA).		




Pharmacia	Biotech	(UK).	Reblot	plus	strong	stripping	solution	was	from	Millipore	(MA	 USA).	 Super	 Signal	West	 Dura	 kit	 was	 from	 Perbio	 (UK).	 Absolute	 ethanol,	isopropanol,	 methanol,	 sodium	 dodecyl	 sulphate	 (SDS),	 sodium	 chloride	 (NaCl),	Triton	X-100	and	glycerol	were	from	BDH	Lab.	Supplies	(Poole,	UK).	Kaleidoscope	pre-stained	standards	were	 from	Biorad	(CA,	USA).	Tris	Base,	Tris-HCl,	hydrogen	peroxide,	 luminol	and	coumaric	acid	were	from	Sigma	(Poole,	UK).	SeeBlue	Plus2	pre-stained	 standards	 were	 purchased	 from	 Invitrogen	 Ltd	 (Paisley,	 UK).	 CL-XPosure	film	was	from	Thermo	Scientific	(UK).	Taq	DNA-polymerase,	dNTPs,	1KB	plus	DNA	ladder,	100mM	dNTP	set	and	Agarose	were	from	Invitrogen	Ltd	(Paisley,	UK).	
2.1.3	Reagents	for	immunolabelling	Paraformaldehyde	was	obtained	 from	Fluka	Chemicals	Ltd.	 (Buchs,	 Switzerland).	Triton	X-100,	 lysine	and	Hoechst	dye	H33258	were	obtained	 from	Sigma	 (Poole,	UK).	Citifluor	was	from	Citifluor	Ltd.	(London,	UK)	HCl	and	glycerol	were	obtained	from	BDH	(Lutterworth,	UK).		





P0-Cre	mice	Transgenic	mice	expressing	mP0TOT(Cre)	transgene	(P0-Cre)	were	driven	by	the	mpz	 promoter.	 P0-Cre	 transgene	 activates	 Cre-mediated	 recombination	specifically	 in	Schwann	cells	between	the	ages	of	E13.5	and	E14.5.	Strong	P0-Cre	activity	is	only	detected	in	the	peripheral	nerve,	with	slight	activity	in	the	occipital	lobe	of	the	cerebral	cortex,	Purkinje	cell	 layer	of	the	cerebellum	and	in	the	heart.	The	P0-Cre	mice	were	provided	by	Dr	L.	Wrabetz	and	Dr	M.L.	Feltri	(Hunter	James	Kelly	Research	Institute,	Buffalo,	NY,	USA).	P0-Cre	mice	have	been	used	extensively	in	Schwann	cell	reports	for	the	ablation	of	‘floxed’	genes.	P0-Cre	mice	were	used	in	this	study	to	generate	Schwann	cell	specific	ablation	of	c-Jun	as	described	below.		







Substratum	coating	of	Poly-D-lysine	and	Poly-L-lysine	Round	13-mm	glass	 coverslips	were	 baked	 in	 an	 oven	 for	 4	 hours	 at	 140°C	 and	were	coated	with	20	μg/ml	Poly-D-Lysine	(PDL)	in	distilled	H2O	for	rat	Schwann	cells,	or	20	μg/ml	Poly-L-Lysine	(PLL)	in	distilled	H2O	for	mouse	Schwann	cells,	for	3	hours	at	RT.	Coverslips	and	dishes	were	then	washed	3	times,	for	15	min	each	in	sterilised	water	and	dried	overnight	 in	a	class	 I	 tissue	culture	hood	before	being	stored	 in	 sterile	 and	 desiccated	 (in	 the	 presence	 of	 silica	 gel)	 conditions	 at	 RT.	35	mm	and	60	mm	tissue	culture	dishes	were	coated	with	PDL	(20	μg/ml)	or	PLL	(20	μg/ml)	for	4	hours	at	RT.	The	solution	was	removed	and	the	dishes	rinsed	once	with	distilled	H2O	and	allowed	to	air-dry	overnight	in	a	class	I	tissue	culture	hood.			
Laminin	A	15-μl	drop	of	laminin	solution	(diluted	in	DMEM,	20	μg/ml)	was	placed	into	the	centre	 of	 each	 glass	 coverslip,	 or	 completely	 covering	 the	 culture	 dish	 and	incubated	for	30	min	at	RT.	The	laminin	solution	was	removed	immediately	prior	to	plating	cells	onto	the	coverslip.		
2.3.2	Tissue	Culture	Media	




(100	μg/ml),	 thyroxine	(400	ng/ml),	progesterone	(60	ng/ml),	glutamine	(1	mM),	penicillin-streptomycin	 (100	U/ml),	 triiodothyronine	 (10.1	ng/ml)	 and	 selenium	(160	ng/ml)	and	insulin	(10-6	M).	
2.2.3	Pharmacological	Agents	The	Rho	Kinase	II	(ROCKII)	inhibitor	Y-27632	was	purchased	from	Sigma	Aldrich,	dissolved	in	DMSO	and	used	at	a	final	concentration	of	10	µM	for	all	experiments.	The	c-Src	inhibitor	SU6656	was	also	purchased	from	Sigma,	dissolved	in	DMSO	and	used	at	a	final	concentration	of	2	µM	for	all	experiments.	Mitomycin-C	was	used	to	inhibit	cellular	proliferation	in	the	migration	assays.	I	purchased	this	from	Sigma,	and	the	compound	was	dissolved	in	H20	and	used	at	a	concentration	of	10	µg/ml.	




then	 the	 5%	 horse	 serum/DMEM	 was	 added	 to	 prevent	 further	 enzymatic	digestion.	 The	 digested	 cells	 were	 then	 transferred	 to	 a	 15-ml	 Falcon	 tube	 and	centrifuged	at	1,000	rpm	for	10	min.	The	cell	pellet	was	then	resuspended	in	2	ml	of	5%	horse	serum	+	Pen/Strep	and	 transferred	 to	a	 laminin-PLL-coated	35-mm	tissue	culture	dish.	Ara-C	was	added	to	the	dish	at	a	final	concentration	of	10-5	M	and	the	cells	were	incubated	at	37˚C	in	5%	CO2	for	3	days	to	eliminate	proliferating	fibroblasts.	 After	 3	 days,	 the	 cells	 were	 trypsinised	 and	 re-plated	 into	 a	 35-mm	dish	 containing	 Schwann	 cell	 expansion	 medium	 (Defined	 Medium	 containing	0.5%	horse	serum	(1:200),	100	μM	dbcAMP	(1:500)	and	10	ng/ml	NRG1	(1:500).	The	cells	were	used	 for	 further	experiments	once	the	dish	had	become	confluent	(~7-10	days	following	purification),	but	were	placed	in	DM	without	any	mitogenic	factors	for	12	hours	until	experimental	reagents	were	added.	




ml	of	PBS.	Three	cycles	of	 freeze-thawing	using	the	-80˚C	freezer	and	37˚C	water	bath	were	completed,	and	the	cell	 suspension	was	centrifuged	at	3,000rpm	for	5	min.	The	supernatant	was	passed	through	a	0.2	µm	filter	and	the	virus-containing	solution	was	aliquoted	and	stored	at	-80˚C.	The	 viruses	 were	 then	 titred	 by	 infecting	 Ara-C	 purified	 Schwann	 cells	 with	different	 volumes	 of	 the	 virus.	 The	 volume	 that	 resulted	 in	 >95%	 infection	 (as	determined	by	immunolabelling	Cre,	or	expression	of	GFP)	and	no	cell	death	was	chosen.	Viral	 titration	was	carried	out	each	time	when	preparing	new	adenoviral	stocks.	
2.3.6	Adenoviral	infection	The	adenoviruses	were	used	to	infect	the	expanded	primary	mouse	Schwann	cell	cultured.	 Briefly,	 the	 medium	 of	 confluent	 35-mm	 dishes	 was	 changed	 from	expansion	medium	 to	DM	containing	0.5%	horse	 serum	and	2	µM	Forskolin	and	Insulin	(10-6	M).	A	volume	of	adenovirus	was	added	(determined	by	titration)	and	after	24	hours,	the	medium	was	exchanged	with	DM	containing	0.5%	horse	serum	and	left	for	2	days	before	being	used	in	experiments.	
2.4	Migration	Assays	




pipetted	into	the	top	compartment	of	a	Transwell	(pores	size	of	8	µm,	placed	in	a	24-well	 plate).	 The	 contents	 of	 the	 lower	 compartments	 were	 varied	 across	different	experimental	conditions.	Cells	were	allowed	to	migrate	 for	12	hours.	At	the	end	of	the	experiment,	the	Transwell	membrane	was	fixed	with	4%	PFA	for	10	min,	washed	three	times	with	PBS	and	the	upper	side	of	the	membrane	was	gently	scrapped	 with	 a	 cotton	 bud	 to	 remove	 non-migrated	 cells.	 The	 membrane	 was	stained	with	dapi,	cut	out	of	the	Transwell	supports	and	mounted	onto	slides.	The	total	 number	 of	 nuclei	 (representing	 migrated	 cells)	 were	 counted	 across	 the	entire	membrane	using	a	fluorescent	microscope.	






































2.5	Sciatic	nerve	transection	injury	models	All	surgical	procedures	were	carried	out	under	UK	Home	Office	guidelines,	using	sterile	surgical	technique.	Mice	were	shaved	in	the	region	of	the	leg	and	lower	back	and	subsequently	anaesthetized	with	2%	isofluorane.	For	the	complete	transection	experiment,	 the	 sciatic	nerve	was	exposed	and	 transected	at	 the	mid-thigh	 level,	approximately	1	cm	above	the	point	at	which	the	nerve	trifurcates	into	the	tibial,	peroneal	 and	 sural	 branches..	 For	 the	 partial	 transection	 injury	 model,	 no.	 5	forceps	were	used	to	gently	part	the	tibial	and	peroneal	branches	to	create	a	gap	of	sufficient	 size	 to	 insert	 the	 blades	 of	 the	 surgical	 scissors	 and	 then	 transect	 the	peroneal	branch.	Care	was	taken	to	separate	the	two	branches	in	small	area	so	that	following	 transection,	 the	 proximal	 and	 distal	 stumps	 were	 still	 attached	 to	 the	tibial	nerve	and	kept	in	close	proximity	to	each	other.	The		skin	was	closed	using	veterinary	autoclips	and	animals	were	left	to	recovered	in	a	heated	box.		










2.7.1	Protein	extraction	The	 distal	 stumps	 of	 transected	 nerves	were	 snap	 frozen	 in	 liquid	 nitrogen	 and	transferred	to	tubes	containing	10-12	10B	lysing	matrix	beads	and	100	μl	of	lysis	buffer	(25	mM	Tris-HCl	pH	7.4,	95	mM	NaCl,	10	mM	EDTA,	2%	SDS	and	proteinase	and	 phosphatase	 inhibitors).	 The	 nerve	 samples	 were	 placed	 in	 a	 Fast-prep	homogeniser	 for	 45	 sec	 at	 level	 6,	 chilled	 on	 ice	 and	 then	 subjected	 to	 repeat	homogenisation	at	the	same	setting.	The	resulting	lysates	were	then	centrifuged	at	4˚C	 at	 10,000	 rpm	 for	 2	 min.	 Supernatants	 were	 transferred	 to	 new	 tubes	 and	centrifuged	again	at	 the	same	settings.	The	new	supernatants	were	collected	and	stored	at	-80˚C.	

















value	 that	 was	 <30.	 PCR	 products	 were	 run	 on	 an	 agarose	 gel	 to	 check	 for	 the	presence	 one	 band.	 Standard	 curves	 were	 carried	 out	 on	 the	 primers	 for	 each	cDNA	sample,	and	primers	were	only	accepted	if	R2>0.98	and	there	was	a	gradient	of	-3.2	to	-3.5	(Efficiency,	>95%).	
2.8.3	RT-qPCR	analysis	The	data	from	the	RT-qPCR	were	normalized	to	GAPDH	and	YWHAZ	as	these	had	the	least	variability	of	all	housekeeping	genes	tested	between	the	control	and	c-Jun	knockout	samples.	This	was	done	using	the	Biorad	CFX	Manager	Software	(version	1.6).	 Fold	 change	 of	 expression	 of	 c-Jun	 knockout	 compared	 to	 control	 was	calculated	using	the	2-ΔΔCt	method	using	the	Biorad	CFX	software.	
2.9	Immunolabelling	
2.9.1	Antibodies	
Antibody	 Supplier	 Host	Species	 Application	










	2.9.5	Nerve	wholemount	immunohistochemistry	The	 peroneal	 nerve	 was	 carefully	 cut	 away	 from	 the	 tibial	 nerve	 with	 small	dissecting	 scissors,	 immediately	 prior	 to	 fixation	 with	 4%	 paraformaldehyde	overnight	at	4˚C.	The	nerve	sample	was	then	rinsed	with	PTX	(1%	triton	X-100	in	PBS)	three	times	for	10	min	each	and	then	incubated	in	blocking	buffer	(10%	FBS	in	 PTX)	 overnight	 at	 4˚C	 in	 a	 2-ml	 eppendorf	 tube.	 The	 primary	 antibodies	(Neurofilament	and	S100)	were	diluted	 in	10%	FBS-PTX	and	 incubated	with	 the	sample	for	72	hours	at	4˚C	with	gentle	shaking.	The	sample	was	then	rinsed	three	times	for	15	min	each,	followed	by	washing	in	PTX	for	6	hours	at	4˚C.	The	PTX	was	changed	 each	 hour	 and	 the	 samples	 left	 to	 wash	 overnight	 in	 the	 final	 wash.	Secondary	antibodies	were	diluted	in	10%	FBS-PTX	and	incubated	for	48	hours	at	4˚C	with	gentle	shaking.	The	samples	were	then	rinsed	in	PTX	three	times	for	15	mins	each,	followed	by	washing	overnight	in	PTX.	The	nerve	was	then	cleared	with	25%,	 50%	 and	 75%	 glycerol	 in	 PBS	 until	 the	 tissue	 sinks.	 Samples	 were	 then	mounted	 onto	 a	 coverslip	 and	 slide	 using	 Citifluor	 mounting	 medium	 and	 nail	varnish.	 The	 samples	 were	 visualised	 using	 a	 microscope	 (Leica	 SP2	 confocal	microscope),	 and	 a	maximum	 projection	 of	 30	 stacks	was	 created.	 Images	were	imported	into	Adobe	Photoshop.		
























Figure	 3.1:	 Deletion	 of	 c-Jun	 in	 Schwann	 cells	 increases	 cell	 area	 and	

















introducing	c-Jun	into	the	knockout	cells	would	restore	normal	cellular	migration.	This	was	achieved	by	infecting	the	knockout	cells	with	an	adenovirus	expressing	c-Jun	 and	 examining	 their	migration	 in	 response	 to	NRG1.	 Figure	 3.3B	 shows	 that	restoring	 c-Jun	 in	 knockout	 cells	 does	 indeed	 restore	 cell	 migration	 to	 a	 level	similar	to	that	of	the	control	(no	significant	difference),	and	elevating	c-Jun	levels	in	wildtype	Schwann	cells	leads	to	a	slight	increase	in	cell	migration	(P<0.01).	In	order	to	confirm	the	deficient	migration	of	c-Jun	knockout	Schwann	cells,	an	 additional	 assay	 measuring	 migration	 in	 response	 to	 NRG1	 was	 carried	 out	using	 the	wound	assay	 [described	 in	Chapter	2	and	(Meintanis	et	al.	2001)].	The	results	from	this	experiment	confirmed	that	deletion	of	c-Jun	leads	to	a	reduction	in	Schwann	cell	migration	(Fig.	3.2C).					
















Figure	 3.3:	 Schwann	 cell	 c-Jun	 is	 required	 for	 migration	 on	 collagen	 and	




3.2.4	c-Jun	loss	disrupts	the	Schwann	cell	actin	cytoskeleton	The	 previous	 experiments	 show	 that	 c-Jun	 deletion	 causes	 significant	morphological	 changes	 to	 Schwann	 cells,	 affecting	 their	 ability	 to	 migrate.	 This	phenotype	has	a	significant	affect	on	the	sensitivity	of	these	cells	to	pro-migratory	signals,	 such	as	 serum,	NRG1,	 laminin	and	collagen.	For	 this	 reason,	 I	decided	 to	look	 at	 the	 arrangement	 of	 the	 actin	 cytoskeleton	 in	 these	 cells.	 Actin	polymerization	 and	 formation	 of	 actin	 filaments	 is	 strongly	 associated	 with	changes	in	cell	shape,	most	notably	the	formation	of	stress	fibers	and	lamellipodia.	Figure	3.4	shows	Schwann	cells	labeled	with	fluorescein-phalloidin,	which	binds	to	actin	inside	the	cell.	Control	Schwann	cells	show	staining	throughout	the	cell.	The	Schwann	 cell	 processes	 are	 so	 narrow	 that	 no	 detailed	 structure	 to	 the	 actin	positive	 staining	 can	 be	 seen.	 In	 comparison,	 in	 c-Jun	 knockout	 cells,	 thick	 actin	stress	fibers	are	visible	at	the	periphery	of	the	cell,	often	completely	encircling	to	form	an	actin	wreath.							
Figure	 3.4:	 Deletion	 of	 Schwann	 cell	 c-Jun	 induces	 actin	 cytoskeleton	
































































































































Figure	 4.1:	 In	 vitro	 deletion	 of	 Schwann	 cell	 c-Jun	 does	 not	 alter	 the	







4.2.2	Deletion	of	c-Jun	does	not	regulate	Schwann	cell	expression	of	c-Src	To	determine	directly	whether	 the	 removal	 of	 c-Jun	 in	 Schwann	 cells	 affects	 the	expression	 of	 c-Src,	 I	 performed	 immunolabelling	 of	 control	 and	 c-Jun	 knockout	cells	with	antibodies	against	c-Src.	Figure	4.2A	shows	the	distribution	of	c-Src	and	actin	in	the	control	and	c-Jun	knockout	Schwann	cells.	The	immunolabelling	in	the	image	 shows	a	 fairly	 even	distribution	of	 c-Src	 in	 the	 cytoplasm	of	 the	knockout	cell,	and	it	appears	to	be	absent	from	the	cell	cortex.	The	control	wildtype	Schwann	cell	 also	 shows	 expression	 of	 c-Src	 in	 the	 cytoplasm.	 In	 this	 case	 it	 is	 hard	 to	describe	a	specific	subcellular	location	of	this	protein	as	the	cell	processes	are	very	narrow	 but	 the	 overall	 brightness	 of	 the	 c-Src	 labeling	 in	 the	 control	 and	 c-Jun	knockout	 cells	 is	 similar.	 I	 also	 wished	 to	 investigate	 whether	 this	 observation	would	be	replicated	after	nerve	 injury.	To	determine	 the	protein	 level	of	c-Src	 in	






































Figure	 4.2:	 Deletion	 of	 c-Jun	 does	 not	 enhance	 Schwann	 cell	 expression	 of	



















































Figure	 4.4:	 Inhibition	 of	 ROCKII	 rescues	 the	 c-Jun	 knockout	 migration	
phenotype	
A wound assay was performed using c-Jun knockout Schwann cells seeded on laminin-
coated coverslips. Knockout cells were incubated with inhibitor for ROCKII (Y27632, 

















Figure	 4.5:	 Inhibition	 of	 c-Src	 in	 wildtype	 Schwann	 cells	 mimics	 the	 c-Jun	


















genes	 that	are	known	 to	 regulate	Schwann	cell	migration	and	cytoskeleton	
































































Figure	 4.7	 c-Jun	 deletion	 in	 Schwann	 cells	 does	 alter	 the	 mRNA	 levels	 of	
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